Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1056-1062
Published online before print August 28, 2006, doi: 10.1161/CIRCULATIONAHA.106.620864
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/10/1056    most recent
CIRCULATIONAHA.106.620864v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jolliffe, C. J.
Right arrow Articles by Janssen, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jolliffe, C. J.
Right arrow Articles by Janssen, I.
Related Collections
Right arrow Risk Factors
Right arrowRelated Article

(Circulation. 2006;114:1056-1062.)
© 2006 American Heart Association, Inc.


Pediatric Cardiology

Distribution of Lipoproteins by Age and Gender in Adolescents

Courtney J. Jolliffe, MSc; Ian Janssen, PhD

From the School of Kinesiology and Health Studies (C.J.J., I.J.) and Department of Community Health and Epidemiology (I.J.), Queen’s University, Kingston, Ontario, Canada.

Reprint requests to Ian Janssen, PhD, School of Kinesiology and Health Studies, Queen’s University, 69 Union St, Kingston, Ontario, Canada, K7L 3N6. E-mail janssen{at}post.queensu.ca

Received February 13, 2006; revision received June 13, 2006; accepted June 23, 2006.

Background— The current National Cholesterol Education Program lipoprotein classification system for children and adolescents is recommended for use among 2- to 19-year-olds. This classification system does not take into account gender differences or the natural fluctuations in lipoprotein concentrations that occur with growth and maturation.

Methods and Results— Data from the National Health and Nutrition Examination Surveys were used to develop age- and gender-specific thresholds that can be used to denote abnormal levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides. Each curve was linked to the adult National Cholesterol Education Program Adult Treatment Panel III lipoprotein thresholds using LMS (Lambda-Mu-Sigma) growth curve regression methods. A series of growth curves and tables are presented that can be used to diagnose high-risk lipoprotein levels in the clinical and research settings. For example, in 1-year increments for males starting at age 12 and extending to age 19 years, the high-risk thresholds for total cholesterol were 6.03, 5.83, 5.70, 5.70, 5.77, 5.88, 6.02, and 6.16 mmol/L. The corresponding high-risk threshold for adults (≥20 years) is 6.22 mmol/L.

Conclusions— The present study is the first attempt at developing age- and gender-specific lipoprotein threshold concentrations for adolescents. This new classification system should provide a more accurate diagnosis of high-risk lipoprotein levels and associated cardiovascular risks in adolescents.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 114: 985. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Tomaszewski, F. J. Charchar, T. Barnes, M. Gawron-Kiszka, A. Sedkowska, E. Podolecka, J. Kowalczyk, W. Rathbone, Z. Kalarus, W. Grzeszczak, et al.
A Common Variant in Low-Density Lipoprotein Receptor-Related Protein 6 Gene (LRP6) Is Associated With LDL-Cholesterol
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1316 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. M. Lee, A. Gebremariam, P. Card-Higginson, J. L. Shaw, J. W. Thompson, and M. M. Davis
Poor Performance of Body Mass Index as a Marker for Hypercholesterolemia in Children and Adolescents
Arch Pediatr Adolesc Med, August 1, 2009; 163(8): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. G. Magnussen, A. Venn, R. Thomson, M. Juonala, S. R. Srinivasan, J. S.A. Viikari, G. S. Berenson, T. Dwyer, and O. T. Raitakari
The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Daniels
Can lipid and lipoprotein concentrations in childhood predict adult atherosclerosis?
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 870 - 871.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. P. August, S. Caprio, I. Fennoy, M. Freemark, F. R. Kaufman, R. H. Lustig, J. H. Silverstein, P. W. Speiser, D. M. Styne, and V. M. Montori
Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4576 - 4599.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. O. Kwiterovich Jr.
Recognition and Management of Dyslipidemia in Children and Adolescents
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4200 - 4209.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. O. Kwiterovich
Cut Points for Lipids and Lipoproteins in Children and Adolescents: Should They Be Reassessed?
Clin. Chem., July 1, 2008; 54(7): 1113 - 1115.
[Full Text] [PDF]


Home page
CirculationHome page
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al.
Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study
Circulation, January 1, 2008; 117(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan
Review: Obesity and cardiometabolic syndrome in children
Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81.
[Abstract] [PDF]


Home page
LupusHome page
S. Ardoin, C. Sandborg, and L. Schanberg
Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 618 - 626.
[Abstract] [PDF]


Home page
CirculationHome page
B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels
Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
Circulation, April 10, 2007; 115(14): 1948 - 1967.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. S. Gidding
New Cholesterol Guidelines for Children?
Circulation, September 5, 2006; 114(10): 989 - 991.
[Full Text] [PDF]